DE60023119D1 - Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere - Google Patents

Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere

Info

Publication number
DE60023119D1
DE60023119D1 DE60023119T DE60023119T DE60023119D1 DE 60023119 D1 DE60023119 D1 DE 60023119D1 DE 60023119 T DE60023119 T DE 60023119T DE 60023119 T DE60023119 T DE 60023119T DE 60023119 D1 DE60023119 D1 DE 60023119D1
Authority
DE
Germany
Prior art keywords
cyclooxygenase
administration
compositions
hemmer
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60023119T
Other languages
English (en)
Other versions
DE60023119T2 (de
Inventor
Timothy Keane
R Schuh
L Scrivner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22409943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60023119(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of DE60023119D1 publication Critical patent/DE60023119D1/de
Publication of DE60023119T2 publication Critical patent/DE60023119T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60023119T 1999-03-10 2000-03-09 Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere Revoked DE60023119T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12364499P 1999-03-10 1999-03-10
US123644P 1999-03-10
PCT/US2000/006097 WO2000053149A2 (en) 1999-03-10 2000-03-09 Method and composition for administering a cyclooxygenase-2 inhibitor

Publications (2)

Publication Number Publication Date
DE60023119D1 true DE60023119D1 (de) 2006-02-23
DE60023119T2 DE60023119T2 (de) 2006-07-20

Family

ID=22409943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023119T Revoked DE60023119T2 (de) 1999-03-10 2000-03-09 Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere

Country Status (9)

Country Link
EP (2) EP1158977B1 (de)
JP (1) JP2002538189A (de)
AT (1) ATE306263T1 (de)
AU (1) AU778538B2 (de)
CA (1) CA2363590A1 (de)
DE (1) DE60023119T2 (de)
ES (1) ES2249253T3 (de)
NZ (1) NZ513965A (de)
WO (1) WO2000053149A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100793668B1 (ko) * 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
CN1679556A (zh) * 1999-12-08 2005-10-12 法马西亚公司 维得克西组合物
PT1239857E (pt) * 1999-12-22 2006-07-31 Pharmacia Corp Composicoes de libertacao dupla de um inibidor de ciclo-oxigenase-2
AU2001275004A1 (en) * 2000-06-01 2001-12-11 Pharmacia Corporation Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation
AU2003216920A1 (en) 2002-04-08 2003-10-20 Glaxo Group Limited (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
EP1534305B9 (de) 2003-05-07 2007-03-07 Osteologix A/S Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
EP0828718A1 (de) * 1995-06-02 1998-03-18 G.D. SEARLE & CO. Heterocyclo-substituierte hydroxaminsäurederivate als cyclooxygenase-2 und 5-lipoxygenase inhibitoren
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
ATE211918T1 (de) * 1996-10-21 2002-02-15 Morten Sloth Weidner Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium
TR199901703T2 (xx) * 1996-11-19 2000-07-21 G.D. Searle & Co. Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi.
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
ES2249253T3 (es) 2006-04-01
EP1158977B1 (de) 2005-10-12
EP1637137A2 (de) 2006-03-22
DE60023119T2 (de) 2006-07-20
JP2002538189A (ja) 2002-11-12
EP1158977A2 (de) 2001-12-05
AU778538B2 (en) 2004-12-09
WO2000053149A2 (en) 2000-09-14
AU3732600A (en) 2000-09-28
CA2363590A1 (en) 2000-09-14
EP1637137A3 (de) 2006-07-05
ATE306263T1 (de) 2005-10-15
WO2000053149A3 (en) 2000-12-28
NZ513965A (en) 2004-04-30
EP1158977A4 (de) 2003-09-03

Similar Documents

Publication Publication Date Title
FI934891A (fi) Kombinerade kalcium- och vitamin d-supplement
ATE243943T1 (de) Verfahren zur herstellung einer zusammensetzung zum schutz eines fleischfressenden haustieres gegen krankheiten des abnormalen kohlenhydrat- metabolismus
NZ519980A (en) Pet food composition for treating helicobacter species in pets
BRPI0512926A (pt) formulação de dieta para osteoartrite canina
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
DE60023119D1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
DE60042807D1 (de) Zusaetze fuer krustentier- bzw. fischfuttermittel sowie futtermittel
NZ512086A (en) Method of increasing fat firmness and improving meat quality in animals
ATE258435T1 (de) Pinolensäure gegen diabetes
GB2355196A (en) Companion animal therapeutic treat
EP1550443A4 (de) Zusammensetzung gegen stressbedingte erkrankungen
ATE383082T1 (de) Reduzierung des e. coli-gehaltes in rindfleisch
AU6245801A (en) Food for slowing down feed intake speed in dogs
ATE355741T1 (de) Verfahren zur herstellung von nährstoffen, nährstoffe und verfahren zur abgabe von nährstoffen
PT1233678E (pt) Formulacoes zootecnicas que compreendem acidos biliares
EE200300406A (et) Meetod loomasööda lisandina kasutatava D-pantoteenhappe ja/või tema soolade saamiseks
EP1163903A3 (de) Methanal - Injektion zur Behandlung epidemischer Tierkrankheiten
HUP0303871A2 (hu) Baromfiak egészségi állapotának javítása a tojásba adott karnitin injekció révén
UA34330A (uk) Кормова добавка для птиці
GB0003234D0 (en) Method of treatment
BR0215014A (pt) Método aperfeiçoado para o tratamento de produtos alimentìcios, produtos de alimentos para animais ou produtos agrìcolas com um composto de polieno antifúngico
MD1090G2 (ro) Compoziţie nutritivă pentru hrănirea albinelor
BG103087A (en) Method for the preparation of naphthiridons and intermediate compounds
JP2003246728A5 (de)
EP1370158A4 (de) Verfahren und mittel zur behandlung von krebs bei haustieren

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation